Practice pattern of non‐muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web‐based survey
Authors:
- 11 September 2019
- journal article
- research article
- Published by Wiley in International Journal of Urology
- Vol. 26 (12) , 1121-1127
Abstract
Objectives: To investigate the treatment pattern of non‐muscle invasive bladder cancer patients among urologists in Japan, Korea and Taiwan, with emphasis on compliance with important treatment guidelines.Methods: A Web‐based questionnaire survey was conceived by representative members of each country's urological oncology society and was open from June 2016 to February 2017 to each society's members. Descriptive statistics and multinomial logistic regression analysis were used.Results: A total of 2334 urologists were invited and 701 responded to the survey with a response rate of 30.0%. Instruments used during transurethral resection of bladder cancer varied significantly between countries and depended on their availability. The re‐transurethral resection rate for pT1 or high‐grade disease >50% of the time was significantly higher in Japan than in the other two countries, but the collective rate was just 49%. The frequency of intravesical therapy in intermediate‐ to high‐risk disease was generally consistent across countries. However, the choice of agent between chemotherapy and bacillus Calmette–Guérin was significantly different between countries. Maintenance bacillus Calmette–Guérin was used <10% of the time by 45% of respondents, the most important reasons being fear of side‐effects, followed by a lack of efficacy and shortage of drug supply.Conclusions: There are significant differences between Japan, Korea and Taiwan in the management of intermediate‐ to high‐risk non‐muscle invasive bladder cancer. The results of this survey can serve as the basis for joint efforts to develop common clinical guidelines.Keywords
This publication has 19 references indexed in Scilit:
- Comparison of Perioperative Outcomes including Severe Bladder Injury between Monopolar and Bipolar Transurethral Resection of Bladder Tumors: A Population Based ComparisonJournal of Urology, 2014
- Surveying Clinicians by WebEvaluation & the Health Professions, 2013
- Watchful Waiting Versus Intravesical BCG Therapy for High-grade pT1 Bladder Cancer with pT0 Histology After Second Transurethral Resection: Japan Clinical Oncology Group Study JCOG1019Japanese Journal of Clinical Oncology, 2012
- Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic ReviewEuropean Urology, 2011
- Compliance with guidelines for patients with bladder cancerCancer, 2011
- Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian StudyUrologia Internationalis, 2010
- Evidence‐based clinical practice guidelines for bladder cancer (Summary – JUA 2009 Edition)International Journal of Urology, 2010
- Clinical outcome of tumor recurrence for Ta, T1 non‐muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999–2001 report from the Japanese Urological AssociationInternational Journal of Urology, 2009
- Nomograms for Prediction of Disease Recurrence in Patients with Primary Ta, T1 Transitional Cell Carcinoma of the BladderJournal of Korean Medical Science, 2008
- Current Practice in the Management of Superficial Bladder Cancer in the Netherlands and Belgian Flanders: A SurveyEuropean Urology, 2006